QA US brainmachine interface expert to direct new Wyss Center in Geneva

Neuroscientist John Donoghue of Brown University has spent the past decade working on brain-machine interfaces that allow paralyzed people to control prosthetic limbs using only their minds, a project called BrainGate. This summer, he’s packing his bags for Switzerland to become director of the new Wyss Center for Bio- and Neuro-Engineering in Geneva, part of the resurrection of an extensive research facility abandoned by pharma giant Merck Serono in 2012. The firm sold the site last year to Swiss billionaires Hansjörg Wyss and Ernesto Bertarelli—Bertarelli used to run the biotech firm Serono before Merck purchased it. The new center, funded with more than $100 million from a foundation started by Wyss, will host more than a dozen new laboratories devoted to research in areas such as neuroengineering and regenerative engineering. Science talked to Donoghue about the move. This interview has been edited for clarity and brevity.Q: What’s the mission of the new Wyss Center and your vision for the program as director? Click to view the privacy policy. Required fields are indicated by an asterisk (*) Email Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Sign up for our daily newsletter Get more great content like this delivered right to you! Country A: The goal of the new Wyss Center is to make neuroprosthetics that will be practical in the real world. A lot of times we do things that look really cool to the media, but are they something that will help people in everyday life? Sometimes they’re not, or sometimes the barriers to getting them out are so formidable that they don’t get out.BrainGate is obviously why I’m so closely aligned with the mission. We have been working for now a solid decade in the human realm trying to get a product that is really able to be used by people every day, and we’re not there yet.Wyss has really quite substantial resources to provide a stable base for projects like that. The closest thing in the U.S. might be Janelia Farm, where people come to do microscopy because they have exceptionally high-quality instruments that aren’t available elsewhere.Q: Do you think that Europe provides a more stable environment for neuroscience research?A: The U.S. has absolutely extraordinary scientists and neuroscience is amazing here. I am a little disappointed that the U.S. is not investing as heavily as other countries, though. If you look at countries that are investing heavily in industry, education, and science, it’s Germany and Switzerland. Now tell me the two strongest economies in the world? Germany and Switzerland.Q: Officially you are on a 1-year sabbatical from Brown. Do you anticipate coming back to Brown in the future?A: I don’t know. I love Brown, and I never thought I would even think of going someplace else, but to have the chance to shape something like this—it’s hard to turn something that wonderful down.

Recommended Reading

Discuss

Your email address will not be published. Required fields are marked *